Claudin18.2 expression in pulmonary mucinous adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Claudin18.2 expression in pulmonary mucinous adenocarcinoma

Published:2023-07-19 Issue: Volume: Page:
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Wang Yuming,Gao Yike,Zhang Zhiwen,Zhang Zixin,Wang Anqi,Zhao Kun,Zhang Miao,Zhang Sumei,Li Mei,Sun Jian,Guo Dan,Liang Zhiyong

Funder

the National High Level Hospital Clinical Research Funding

CAMS Innovation Fund for Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05150-x.pdf

Reference19 articles.

1. Arpa G, Fassan M, Guerini C, Quaquarini E, Grillo F, Angerilli V, Guzzardo V, Lonardi S, Bergamo F, Lenti MV, Pedrazzoli P, Paulli M, Di Sabatino A, Vanoli A (2022) Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study. Virchows Arch 481(6):853–863

2. Baek JH, Park DJ, Kim GY, Cheon J, Kang BW, Cha HJ, Kim JG (2019) Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer. Anticancer Res 39(12):6973–6979

3. Cao W, Xing H, Li Y, Tian W, Song Y, Jiang Z, Yu J (2022) Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. Biomark Res 10(1):38

4. Duruisseaux M, Antoine M, Rabbe N, Rodenas A, Mc Leer-Florin A, Lacave R, Poulot V, Duchene B, Van Seuningen I, Cadranel J, Wislez M (2017) Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers. Lung Cancer 109:92–100

5. Guo M, Tomoshige K, Meister M, Muley T, Fukazawa T, Tsuchiya T, Karns R, Warth A, Fink-Baldauf IM, Nagayasu T, Naomoto Y, Xu Y, Mall MA, Maeda Y (2017) Gene signature driving invasive mucinous adenocarcinoma of the lung. EMBO Mol Med 9(4):462–481

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary mucinous adenocarcinoma: An overview of pathophysiology and advancements in treatment;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3